- Home
- BWFG vs AVIR Comparison
BWFG vs AVIR Comparison
Compare BWFG & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWFG
- AVIR
- Stock Information
- Founded
- BWFG 2002
- AVIR 2012
- Country
- BWFG United States
- AVIR United States
- Employees
- BWFG N/A
- AVIR N/A
- Industry
- BWFG Major Banks
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- BWFG Finance
- AVIR Health Care
- Exchange
- BWFG Nasdaq
- AVIR Nasdaq
- Market Cap
- BWFG 256.7M
- AVIR 251.7M
- IPO Year
- BWFG N/A
- AVIR 2020
- Fundamental
- Price
- BWFG $30.61
- AVIR $3.09
- Analyst Decision
- BWFG Buy
- AVIR Hold
- Analyst Count
- BWFG 1
- AVIR 1
- Target Price
- BWFG $40.00
- AVIR $6.88
- AVG Volume (30 Days)
- BWFG 13.3K
- AVIR 329.3K
- Earning Date
- BWFG 01-22-2025
- AVIR 03-03-2025
- Dividend Yield
- BWFG 2.61%
- AVIR N/A
- EPS Growth
- BWFG N/A
- AVIR N/A
- EPS
- BWFG 1.17
- AVIR N/A
- Revenue
- BWFG $64,379,999.00
- AVIR N/A
- Revenue This Year
- BWFG N/A
- AVIR N/A
- Revenue Next Year
- BWFG $12.49
- AVIR N/A
- P/E Ratio
- BWFG $26.16
- AVIR N/A
- Revenue Growth
- BWFG N/A
- AVIR N/A
- 52 Week Low
- BWFG $22.47
- AVIR $2.75
- 52 Week High
- BWFG $35.25
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- BWFG 45.46
- AVIR 48.26
- Support Level
- BWFG $31.25
- AVIR $3.04
- Resistance Level
- BWFG $31.66
- AVIR $3.25
- Average True Range (ATR)
- BWFG 0.82
- AVIR 0.13
- MACD
- BWFG -0.06
- AVIR 0.01
- Stochastic Oscillator
- BWFG 25.52
- AVIR 54.29
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses, and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).